4//SEC Filing
Kestenberg-Messina Kaitlin M. 4
Accession 0001140361-25-028449
CIK 0001368514other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 9:00 PM ET
Size
10.1 KB
Accession
0001140361-25-028449
Insider Transaction Report
Form 4
Kestenberg-Messina Kaitlin M.
COO and SVP, Compliance
Transactions
- Tax Payment
Common Stock
2025-07-30$18.59/sh−1,208$22,457→ 488,690 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-07-30−2,500→ 0 totalExercise: $8.98Exp: 2025-07-30→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2025-07-30$8.98/sh+2,500$22,450→ 489,898 total
Footnotes (4)
- [F1]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements and payment by the Reporting Person of the option exercise price. This is not an open market sale of securities. This option was automatically exercised on the expiration date.
- [F2]Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 144,240 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 15,000 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;
- [F3](continued from footnote 2) (iv) 47,500 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 10,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 194,166 shares of common stock directly owned by the reporting person, which includes the option exercise described in footnote 1 and prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
- [F4]The option was granted on July 30, 2015 and is fully vested.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0002017423
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 9:00 PM ET
- Size
- 10.1 KB